Table 3.
Seroprevalence of anti-DENV antibodies, malaria parasites and their co-infections
| Diagnoses | Results | Number (%) |
|---|---|---|
| Anti-dengue virus IgM antibodies (N = 410) | Positive | 101 (24.6) |
| Borderline | 86 (21.0) | |
| Negative | 223 (54.4) | |
| Anti-dengue virus IgG antibodies (N = 367) | Positive | 142 (38.7) |
| Borderline | 75 (20.2) | |
| Negative | 150 (40.8) | |
| Microscopy for hemo-parasites (N = 411) | Positive for falciparum | 37 (9.0) |
| Positive for P. vivax | 5 (1.2) | |
| Positive for mixed of both infections | 2 (0.5) | |
| Total malaria positive | 44 (10.7) | |
| Dengue IgM-malaria Co-infection (N = 410) | Positive for falciparum and anti-dengue IgM | 14 (3.4) |
| Positive for vivax and anti-dengue IgM | 3 (0.7) | |
| Positive for Mixed malaria-dengue IgM | 1 (0.2) | |
| Total positive for malaria and anti-dengue IgM | 18 (4.4) | |
| Dengue IgG-malaria Co-infection (N = 367) | Positive for falciparum and anti-dengue IgG | 16 (4.4) |
| Positive for vivax and anti-dengue IgG | 2 (0.5) | |
| Total positive for malaria and anti-dengue IgG | 18 (4.9) |